SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-124863
Filing Date
2018-04-20
Accepted
2018-04-20 16:05:57
Documents
4
Period of Report
2018-05-31
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d540976ddef14a.htm DEF 14A 219629
2 GRAPHIC g540976g46r88.jpg GRAPHIC 52753
3 GRAPHIC g540976pc1.jpg GRAPHIC 164923
4 GRAPHIC g540976pc2.jpg GRAPHIC 151291
  Complete submission text file 0001193125-18-124863.txt   729192
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38210 | Film No.: 18766708
SIC: 2836 Biological Products, (No Diagnostic Substances)